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LETTER TO THE EDITOR
Autoimmune thyroid disease and urticarial 
vasculitis: is there a significant association?
Ivan Cherrez‑Ojeda1,2* , Emanuel Vanegas1,2, Valeria L. Mata2, Miguel Felix2, German D. Ramon3, 
Sofia Cherrez2,4 and Annia Cherrez2,5
Abstract 
Little is known about the association of urticarial vasculitis (UV) with thyroid autoimmunity. The latter has been mostly 
described in the setting of patients with chronic spontaneous urticaria (CSU). In this letter to the editor, we compare 
UV and CSU through retrospective analyses, which reveal that 41.7% patients with UV presented antithyroperoxidase 
(anti‑TPO) and/or antithyroglobulin antibody (ATA) above the reference range, while only 4% patients with 
CSU had these antibodies elevated. There is a moderately strong association assessed by the Phi coefficient 
(φ = 0.420, p = 0.004). Further research is needed to appropriately address the relationship between UV and thyroid 
autoimmunity and explore any potential underlying pathophysiological process between both diseases.
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Urticarial vasculitis (UV) is identified as a 
clinicopathologic entity that involves clinical features of 
urticaria and histopathologic findings compatible with 
a cutaneous leukocytoclastic vasculitis of small vessels 
with fibrinoid deposits. UV represents a spectrum of 
diseases that differ in severity, ranging from an urticaria 
with minimal vasculitis to a systemic disease that can 
lead to serious organ-specific complications. Certainly, 
urticarial vasculitis is an underdiagnosed disease, to the 
extent that its incidence may vary from 3 to 20% [1]. This 
is due to the lack of a consensus in medical literature 
upon a disease that manifests diversely, with a definite 
diagnosis that relies on a high-tech procedure such as 
biopsy.
Several findings may facilitate its diagnosis, such as 
abnormal acute phase reactants, hypocomplementemia, 
positive antinuclear antibodies (ANA) and other 
laboratory tests that have been extensively described, 
as well as common associations with other clinical 
conditions such as systemic lupus erythematosus 
(SLE), lupus-like disease and Sjogren’s Syndrome [1, 
2]. However, little is known of how UV associates with 
thyroid autoimmunity. The latter has been mostly 
described in the setting of patients with chronic 
spontaneous urticaria (CSU), with evidence suggesting 
that CSU can improve in response to treatment with 
levothyroxine or other thyroid drugs [3]. In this report 
we discuss the potential implication of screening UV 
patients for abnormally elevated IgG anti-thyroid Abs 
(AAbs), as this feature has been described as a predictor 
of hypothyroidism in euthyroid patients [4].
We carried out a retrospective analysis from 2005 to 
2016 involving 98 patients diagnosed with either chronic 
spontaneous urticaria or urticarial vasculitis at Respiralab 
Urticaria Center, Guayaquil-Ecuador. Demographic and 
clinical variables such as age, sex, years with the disease, 
type of urticaria, thyroid function tests and antithyroid 
antibodies were collected using medical records from the 
institution. The diagnostic definitions used for chronic 
spontaneous urticaria and urticarial vasculitis are 
summarized in Table  1 [5–8]. All patients with clinical 
features suggestive of urticarial vasculitis were confirmed 
by biopsy. Thyroid function tests (T3, T4, TSH) were 
categorized into normal, below normal or above normal, 
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while AAbs (antithyroperoxidase, antithyroglobulin 
antibodies) where dichotomized as absent or present.
Descriptive analyses (frequency, percentage, standard 
deviation) were carried out for demographic and clinical 
variables. The Chi square test was applied to analyze the 
fit of distribution and to measure association with the 
Phi coefficient between the diagnosis and the presence/
absence of AAbs. Crude analysis with binomial logistic 
regressions between diagnosis and antithyroid antibodies 
were performed. All statistical analyses were carried out 
using SPSS v24.0 (IBM, Armonk, NY, USA). P < 0.05 was 
considered significant.
Descriptive analyses from the 98 patients involved 
showed that 25.5% (n = 25) were males and 74.5% 
(n = 73) were females. The mean age of the sample 
studied was 38.12 years (SD 15.97), and the mean length 
of the disease since diagnosis was 1.49  years (SD 2.19). 
Concerning the disease, 87.8% (n = 86) patients were 
diagnosed with chronic spontaneous urticaria and 12.2% 
(n = 12) with urticarial vasculitis (Fig. 1).
From 12 patients with urticarial vasculitis, 41.7% 
(n = 5) presented antithyroperoxidase (anti-TPO) and/
or antithyroglobulin antibody (ATA) above the reference 
range (p = 0.564), while only 4% (n = 4) out of the 86 
patients with CSU had these AAbs elevated (p = 0.000). 
The observed frequency for patients with AAbs above 
normal with urticarial vasculitis was greater than the 
expected value, while for CSU patients it was less than 
expected, with a moderately strong association assessed 
by Phi coefficient (φ = 0.420, p = 0.004). Patients with UV 
were 14.64 times more likely to have abnormally elevated 
levels of AAbs than CSU patients (p = 0.001). Regarding 
complement 66.6% (n = 8) of patients had low levels 
(defined by low C3 and C4), and 8.3% (n = 1) had normal 
levels. Unfortunately, 25% (n = 3) of patients did not have 
complement measurements. There were no UV patients 
presenting with associated SLE, or related collagen 
disorder.
With respect to thyroid profile on individuals with 
elevated AAbs, we found that 75% (n = 3) patients with 
CSU were euthyroid, while 25% (n = 1) were compatible 
with subclinical hyperthyroidism. On the other hand, 
60% (n = 3) cases diagnosed with UV were euthyroid, 
while 20% (n = 1) were compatible with subclinical 
hypothyroidism and another 20% (n = 1) had T3 levels 
above normal with T4 and TSH in the reference range.
Annual reassessment of thyroid function and AAbs 
levels in UV patients may be recommended, since levels 
of AAbs have shown to predict the future development 
of hypothyroidism in an euthyroid general population 
[4]. In our sample, all patients with elevated AAbs were 
euthyroid, except for three patients, of which two were 
compatible with subclinical hypothyroidism. Currently, 
it is known that the presence of AAbs in the patient 




 Spontaneous development of wheals, angioedema, or both for 
> 6 weeks. Wheals have the following characteristics
  1. Central swelling surrounded by reflex erythema.
  2. Itching, sometimes burning sensation
  3. Skin returning to normal appearance within 30 min to 24 h
Urticarial vasculitis
 Clinical manifestations of urticaria characterized by wheals that are 
painful, burning, and tender in sensation. Lesions tend to last > 24 h 
and are associated with faint residual hyperpigmentation. Biopsy is 
needed to confirm the diagnosis, with the following findings
  1. Inflammatory injury to capillaries and postcapillary venules
  2. Leukocytoclasis with fibrinoid deposits as signs of direct vessel 
damage
Fig. 1 Anti‑thyroid antibodies (AAbs) and thyroid function profile on chronic spontaneous urticaria (CSU) and urticarial vasculitis (UV) patients
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with CSU does not associate with abnormal thyroid 
function, since most patients are usually euthyroid [9]. 
However, in a minority of patients with Hashimoto’s 
thyroiditis, administration of levothyroxine may improve 
chronic urticaria symptoms, hypothetically highlighting 
a common pathogenesis between such entities [10]. It 
is not known if treating thyroid disease in UV patients 
might resolve urticaria symptoms in some degree, a point 
we consider of interest for future research.
As relevant limitations to our study we must mention 
the small sample size and retrospective nature. 
Nevertheless, it would be interesting to develop new 
research to appropriately address the relationship 
between UV and thyroid autoimmunity, to explore 
if there is an underlying pathophysiological process 
between both diseases, and to determine if early 
treatment of thyroid disease is recommended. Only this 
data would, in clinical practice, support the screening of 
AAbs in UV patients.
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